The small, discreet2 sensor worn on the back of the upper arm continuously measures the glucose concentration in the body's interstitial fluid. It is worn for up to 14 days and is water-resistant so continues to work while your patients shower, swim or exercise₸. Patients can scan their sensor anytime‡, anywhere₸, even through clothingΩ.
Patients can use the FreeStyle LibreLink app◊ to scan their sensor to read their glucose levels.
The sensor is easily attached to the back of the upper arm. It can be worn up for 14 days.
Excellent accuracy overall — even in the low glucose range when it matters most.3
Patients can check their glucose anytime‡, anywhere₸ with a simple 1-second scan even through clothing.
Dose insulin, confirm hypo or impending hypo, and be alerted when glucose is rapidly changing — all without the need for finger pricks.
The FreeStyle Libre sensor is applied on the back of the upper arm using the applicator. Most FreeStyle Libre system users have reported that applying the sensor was painless.1
Patients will be able to see their current glucose reading, 8-hours of data and a trend arrow that shows where their glucose levels are heading.
The FreeStyle LibreLink app◊ allows patients to interpret their glucose data and help them make informed diabetes management decisions.
Using LibreView,₼ our secure cloud-based system, patients can upload their data to share with their doctor and care team. You will be able to access more in-depth reports to support you in making treatment decisions for your patients.
Patients who use the FreeStyle LibreLink app◊ can remotelyǁ Transfer of glucose data between applications depends on internet connectivity. share their glucose readings with their caregivers and loved ones through the LibreLinkUp app.§
Learn more about the FreeStyle Libre system through our Healthcare Professional education modules.
Explore our tutorial videos to find out how to get started, apply and replace sensor, get glucose readings.
References & Disclaimers
Images are for illustrative purposes only. Not real patient or data.
† Finger pricks are required if your glucose readings do not match symptoms or expectations.
◊ The FreeStyle LibreLink app and the FreeStyle Libre reader have similar but not identical features. Finger pricks are required if readings do not match symptoms or expectations. The FreeStyle Libre sensor communicates with the FreeStyle Libre reader that started it or the FreeStyle LibreLink app that started it. A sensor started by the FreeStyle Libre reader will also communicate with the FreeStyle LibreLink app. The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink requires registration with LibreView.
₸ Sensor is water resistant in up to 1 metre (3 feet) of water for a maximum of 30 minutes. Do not immerse longer than 30 minutes. Not to be used above 10,000 feet.
‡ 60-minute warm-up required when applying the sensor.
φ For a complete glycaemic picture, scan once every 8 hours.
₼ The LibreView website is only compatible with certain operating systems and browsers. Please check www.LibreView.com for additional information.
§ The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.LibreLinkUp.com for more information about device compatibility before using the app. Use of LibreLinkUp and FreeStyle LibreLink requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
Ω The Reader can capture data from the sensor when it is within 1cm to 4cm of the sensor.
ǁ Transfer of glucose data between applications depends on internet connectivity.
1. Haak, Thomas, et al. "Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-treated Type 2 Diabetes: a Multicentre, Open-label Randomised Controlled Trial." Diabetes Therapy 8, no. 1 (2017): 55-73. https://doi.org/10.1007/s13300-016-0223-6.
2. Data on file, Abbott Diabetes Care, Inc.
3. Alva, Shridhara, Timothy Bailey, Ronald Brazg, Erwin S. Budiman, Kristin Castorino, Mark P. Christiansen, Gregory Forlenza, Mark Kipnes, David R. Liljenquist, and Hanqing Liu. “Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes.” Journal of Diabetes Science and Technology, (September 2020).
The "Yes" link below will take you to a website other than Abbott Laboratories. Links to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or any link contained in such websites. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.
Do you want to leave this page?
This is a product-specific website intended for HCPs of Ireland. If you live in another country, please contact your local Abbott office to obtain the correct product information for your country of residence.